A Substudy of the IBCSG 24-02/ SOFT Trial to Investigate Estrogen Suppression for Patients Participating in Arms B and C of the IBCSG 24-02/ SOFT Trial
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Exemestane (Primary) ; Triptorelin (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SOFT-EST
- 08 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 08 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 24 Feb 2016 Planned End Date changed from 1 Jun 2015 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History